HEALL Stock Overview
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$7.24 |
52 Week High | US$7.74 |
52 Week Low | US$6.06 |
Beta | 0 |
1 Month Change | -5.05% |
3 Month Change | -1.30% |
1 Year Change | -3.63% |
3 Year Change | -25.19% |
5 Year Change | 20.22% |
Change since IPO | 9.08% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
HEALL | GB Capital Markets | GB Market | |
---|---|---|---|
7D | 0% | 3.4% | 2.0% |
1Y | -3.6% | 10.7% | 4.5% |
Return vs Industry: HEALL underperformed the UK Capital Markets industry which returned 9% over the past year.
Return vs Market: HEALL underperformed the UK Market which returned 3% over the past year.
Price Volatility
HEALL volatility | |
---|---|
HEALL Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HEALL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HEALL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | n/a | www.ishares.com/uk/institutional/en/products/284216/HEAL |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe.
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Fundamentals Summary
HEALL fundamental statistics | |
---|---|
Market cap | US$1.07b |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs HEALL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEALL income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did HEALL perform over the long term?
See historical performance and comparison